Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
bristol-myers squibb
clinical trials
intercept pharmaceuticals
life sciences
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
obeticholic acid
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
4d molecular therapeutics
abbvie
acne
agenus
allergan
archive
astrazeneca
auris health
avexis
bayer
biomx
biotech
bladder cancer
boulder/denver blog main
boulder/denver top stories
broad institute of mit and harvard
cancer
cancer immunotherapy
cancer vaccines
car-t immunotherapy
celgene
centers for medicare and medicaid services
clinical data
deals
What
disease
fatty
3
×
liver
3
×
approved
drug
known
nash
treatment
alcoholic
allowed
bio
common
companies
condition
damage
data
digital
epidemic
exercise
extract
fda
frenzied
green
growing
health
horizon
important
intercept
issue
key
lead
led
making
marketed
medicine
merck
new
news
nonalcoholic
option
Language
unset
Current search:
liver
×
fatty
×
@slashgear.com
4 years ago
Green tea extract may target common liver issue, but exercise is key
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
